chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lethargy, weakness and sleepiness beginning at about 11am the day following the vaccine. Fever of 101 taken at about 7pm that evening. I slept most of the rest of that day and all night. The next day I was fine, temperature was normal. No further symptoms were experienced.  Starting two days after the vaccine, the lymph nodes under my right arm became swollen and tender; this lasted for about four day. No further symptoms were experienced.
Received 2nd dose of Covid vaccine on Wednesday January 13th at 1040am, soon after had headache but was able to work. Thursday morning at 0330 severe body aches, chills, headache. Symptoms lessened with Tylenol but would come back through Friday the 15th. Had to call out of work Friday the 15th. Saturday the 16th Woke in a sweat and aches/chills have since stopped. Still experiencing headaches
Significant redness, swelling, and fine vesicular formation over entire left side of face. No occular involvement but significant edema of eye lids. Minimal crossover to right side of face. Pt sent to infect disease center of rule out auto innoculation.
This case was reported by a nurse via sales rep and described the occurrence of fever in a 57-year-old female patient who received SHINGRIX. On 27th March 2018, the patient received SHINGRIX. On 27th March 2018, less than a day after receiving SHINGRIX, the patient experienced fever, upset stomach and pain in arm. On an unknown date, the outcome of the fever was recovering/resolving and the outcome of the upset stomach and pain in arm were unknown. It was unknown if the reporter considered the fever, upset stomach and pain in arm to be related to SHINGRIX. Additional information was reported as follows: The case was reported by registered nurse (RN) who was patient. The age at vaccination was not reported but it could be 56 or 57 years. On 27th March 2018 at night, the patient experienced fever with stomach upset and a little arm pain. She stated that she did not check to see what her temperature was, but knew she had a fever since she could not get warm no matter how many clothes she put on. She woke up on 28th March with a fever, but by 6:30pm it was better.
A non-serious spontaneous report of two children administered expired FLUMIST was received from a health professional concerning a nine-year-old patient. Neither the patient's past medical history nor any concomitant medications were reported. The product expired on 08-Dec-2010. The patient received the expired FLUMIST on 14-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. Additional information received on 01-Mar-2011: no late occurring adverse events.
Slight fever and chills; Wiped out for the whole day, lethargic, didn't want to do anything; Slight fever and chills; This is a spontaneous report from a contactable consumer. A 62-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown), via an unspecified route of administration, administered in Arm Left on 18Mar2021 11:45 as DOSE 1, SINGLE (at the age of 62-year-old) for covid-19 immunisation. Medical history included sars-cov-2 test positive from 18Jan2021 to an unknown date (Caller states that he did test positive for Covid on 18Jan2021; confirms that was before his vaccination). There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Reporter stated patient had his first dose a few weeks ago and wanted to report his side effects. Reporter stated the day after (19Mar2021), patient had a slight fever with chills and patient was wiped out for the whole day, didn't want to do anything (on 19Mar2021) and then the day after that he felt normal. Reporter stated that he did test positive for Covid on 18Jan2021; confirmed that was before his vaccination. Stated his second dose was on 08Apr2021. Therapeutic measures were taken as a result of events (Tylenol). The outcome of the events was resolved on 20Mar2021.    No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Moderate diarrhea with dark red blood in stool on day 3; Moderate diarrhea with dark red blood in stool on day 3; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in Left arm on 04Feb2021 08:30 (at the age of 73-years-old) at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No other vaccine in four weeks. The patient experienced moderate diarrhea with dark red blood in stool on day 3 on 07Feb2021 08:00. No treatment received for the events. No COVID prior vaccination, no COVID tested post vaccination. The outcome of the events was not recovered.  Information on the batch/lot number has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PARVOVIRUS INFECTION (Had parvo after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARVOVIRUS INFECTION (Had parvo after vaccination). At the time of the report, PARVOVIRUS INFECTION (Had parvo after vaccination) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications provided. No treatment medications provided.
patient received 1st dose of Hep A vaccine at our center on 05/18/2023. patient's roomate called in on 05/22/2023 to report patinet had pain on neck spine, stiffness on L side of neck and shoulder. Patinet Denies fever.   Instructed patient can observe, treat symptoms, call back to center if condition not improved.
nausea on 1st capsule, threw up & diarrhea @ 2AM; next day diarrhea & has fever of 100;
This case was reported by a pharmacist via call center representative and described the occurrence of tingling tongue in a 78-year-old female patient who received SHINGRIX (batch number Y24KE, expiry date 11th October 2020) for prophylaxis. On 23rd July 2018, the patient received the 1st dose of SHINGRIX. On 23rd July 2018, immediately after receiving SHINGRIX, the patient experienced tingling tongue. On an unknown date, the patient experienced tongue ulceration. On 30th July 2018, the outcome of the tingling tongue was recovered/resolved. On an unknown date, the outcome of the tongue ulceration was recovered/resolved. It was unknown if the reporter considered the tingling tongue and tongue ulceration to be related to SHINGRIX. Additional details were provided as follows: The healthcare professional (HCP) reported that immediately following vaccination with SHINGRIX, the patient reported that her tongue felt funny and was tingling. The tingling never progressed to anything else and resolved 1 week later. On an unknown date, less than a year after receiving SHINGRIX, the patient also reported that small ulcers appeared on one side of her tongue and also resolved. The patient's primary care physician (PCP) instructed the patient to not get the second dose based off of these reactions to dose 1.
site of injection is itching; site of injection feels warm to the touch; site of injection has red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (site of injection is itching), VACCINATION SITE INDURATION (site of injection feels warm to the touch) and VACCINATION SITE ERYTHEMA (site of injection has red mark) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (site of injection is itching), VACCINATION SITE INDURATION (site of injection feels warm to the touch) and VACCINATION SITE ERYTHEMA (site of injection has red mark). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (site of injection is itching), VACCINATION SITE INDURATION (site of injection feels warm to the touch) and VACCINATION SITE ERYTHEMA (site of injection has red mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Came over me quickly - short of breath at first due to  surprise, anxious, achy, fever, chills, tired and sleepy.  Nausea, weak, headache, feeling unwell.  Took a valium to calm down.  Felt better around 10 pm on 2/14 but lasted through 2/15.  Woke up on 2/16 with my bed soaking wet.
This spontaneous case reported by a consumer, describes the occurrence of urinary tract infection (UTI) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 015M20A) for COVID-19 immunization. The patient's past medical history included UTI (a week before first dose had a UTI). Concomitant products included ciprofloxacin for UTI, Synthroid (levothyroxine sodium) for an unknown indication. On Feb 18, 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced urinary tract infection (UTI). At the time of the report, urinary tract infection (UTI) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Reportedly, patient is taking a strong medication (unspecified) for UTI.
Day 1: very dizzy and nausea, HA, warm knot where shot was given Day 2: SAME but knot is now about size of golf ball Day 3: doing better with dizziness and nausea Day 4: now just have golf ball size knot and warm. Only dizzy every now and then. Day 5: SAME Day 6: injection site knot has gone down but my muscle feels like someone "shred it" with lots of pain upon moving it above half way point. Day 7: SAME with dizziness and nausea coming back Day 8: Injection site muscle still sore but improving. Dizzy every now and then still
Woke up due to intense pain in armpit. Felt like I was going to pass out. Checked my heart rate and it was steadily decreasing from 71 to 56. My body went numb and I started to sweat and have cold chills. Heart rate is back to normal, 70.  Pain in under arm on injection side is still very painful and exceeds to the half of the breast as well
Itching, rash on left chin, headache, backache, abdominal pain, difficulty breathing, rapid heart beat, difficulty sleeping, confusion, nightmares, eye sesitivity to light.
Info has been received from a consumer concerning her sone with no allergies or drug reactions who was vaccinated with a dose of MMR. The reporter indicated that the pt had a rash associated with the vaccination (not further specified).  Additional info has been requested. The reporter also noted that the pt developed cellulitis and breathing difficulties after vaccination with a dose of varicella virus vaccine (WAES0503USA04939).
9 hours after shoot woke up feeling very poorly and feverish.  Went to take Tylenol and passed out.  Came to with wife shaking my arm.  Suffered trauma to noise and back during fall as a result of passing out including laceration from hitting face on counter.  After coming to sever body shakes.  Temperature was taken twice and recorded 92.5 and 93.0.  Blood pressure and pulse after moving to couch to lie sit down was normal.  Next day couldn't do much and was very tired.  By second day I was recovered but sealing with injuries from the fall.
Vaccinated 2-9-21 and on 3-1-21 presented at ER with numbness on right side of face and around right eye along with headache pain behind left ear. Presented 3-7-21 with left sided drooping and right side problems resolved.
The nurse was called by the family letting us know that the patient had passed away at home.  No further details were provided,
Patient bled more than normal. Informed the pharmacists that the inject site stung when the vaccine was administered. Later called and complained that her neck and jaw began to hurt.
Pruritis on upper arms, upper legs starting 12 hours after vaccine and lasting up to 48 hours after vaccine. No hive, visible rash, or other symptoms. Pruritis controlled by cetrizine.
Rash papular raised pinkish lesions numbering 10-15 on torso perhaps 2 early vesicles noted.
Resident expired on  1/23/21 . Resident receiving care under  hospice ,diagnosis Acute Myeloid Leukemia.
Started to feel tightness in my throat, dryness in my mouth, numbing lips and warmth throughout my body.  Stopped at Hospital and was treated intravenously with Steroids and Pepcid.  After 2 hours left hospital feeling much better with slight numbness in lips
Right thigh with firm lump at IZ site. Local pink discrete & confluent papular rash extending laterally (to left thigh) and distally to IZ site.
Information has been received from a physician concerning her "approximately 2 year old" son who on an unspecified date was vaccinated with MMR II vaccine (Merck). It was noted that the patient was given a titer test after receiving the vaccination, and the test concluded that the child did not respond to one of the components (component not identified). Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Ongoing hospitalization began 9/23 with cough, weakness, treated with oxygen, remdesivir, dexamethasone for pneumonia due to COVID-19 virus
This is in follow-up to report(s) previously submitted on 9/24/2008; 12/23/2008. Information has been received from a 65 year old female with depression, high blood pressure, chronic fatigue immune dysfunction syndrome, fibromyalgia and sensitivity to a lot of drugs. The patient also had a history of herpes outbreaks (not genital) and stomach upset which was caused by CELEBREX (manufacturer unspecified) who on 25-JUL-2008 was vaccinated subcutaneously in her left upper arm with a dose of ZOSTAVAX (Oka/Merck). Concomitant therapy included hydrocodone, amitriptyline hydrochloride, UNIVASC, XANAX. On approximately 27-JUL-2008 (2 - 3 days after vaccination) the patient experienced a hot, red, encircled hematoma, arm soreness, diarrhea, flu symptoms, tiredness and feeling sick. The patient experienced a hematoma at the injection site, and the injection site was red and inflamed. She also had a tiny rash but it was went away. The patient had severe pain in the arm where she received the injection. The patient was feeling better after the pharmacist advised her to elevate her arm to reduce soreness. The patient said the flu-like symptoms felt like she felt during her non-genital herpes outbreaks or they might be chronic fatigue immune dysfunction syndrome. The hematoma was getting smaller and better. The patient's symptoms were resolving. The patient sought medical attention by taking to the pharmacist. Follow-up information was received from the patient who reported that she had constant pain in the arm that she received the ZOSTAVAX (Oka/Merk) injection. It got really bad at times but it was a constant ache. The patient continued to have severe aching radiating from her left shoulder down her left arm. She also had a hematoma at the injection site. The hematoma at the injection site was still present but it was greatly reduced in size. Initially, it was the sized of a baseball but now it was the size of a nickel. She was of the opinion that she had polymyalgia rheumatica.  The patient had a weakened immune system at the time of vaccination and she indicated that her physician did not warn her not to get the vaccine. No further information is available. On 12-SEP-2008, the patient reported that she still had the pain after receiving ZOSTAVAX (Merck). She had compromised immune system called "chronic fatigue dysfunction" prior to getting ZOSTAVAX (Merck) and "she had this for years". Follow-up information was received from the pharmacist and the patient who reported that the patient was still experiencing pain. The patient had the very sore arm. Follow-up information received on 03-DEC-2008 from the consumer, indicated that she still had horrible stabbing an shooting pain that "comes and goes and gets worse when the weather changes". The consumer believed that she broke out in a rash at the injection site, and now has PHN. The consumer reported that she woke to her Rheumatologist and she believed that she got a small case of shingles from the vaccination and she had PHN. This is a consolidation of two reports concerning the same patient. No further information is available.
Family called doctor on 5/5 with c/o swelling on Right arm, instructed to apply cool compresses and to call back if further problems. Family called again with c/o redness and fever of 102.5 and increase in swelling. Seen by FMD on 5/6 Given Keflex 250/5ml 1 tsp.x 10 days. Instructed to call DOH and report which family did.
She can't drive.; achy; She walks very slow with help; She gets out of breath easy; Sore arm; headache; fatigue; This spontaneous case was reported by a patient family member or friend and describes the occurrence of IMPAIRED DRIVING ABILITY (She can't drive.), PAIN (achy), GAIT DISTURBANCE (She walks very slow with help), DYSPNOEA (She gets out of breath easy) and PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMPAIRED DRIVING ABILITY (She can't drive.), PAIN (achy), GAIT DISTURBANCE (She walks very slow with help), DYSPNOEA (She gets out of breath easy), PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, IMPAIRED DRIVING ABILITY (She can't drive.), PAIN (achy), PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and FATIGUE (fatigue) had not resolved and GAIT DISTURBANCE (She walks very slow with help) and DYSPNOEA (She gets out of breath easy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: Negative. On an unknown date, Colonoscopy: Negative. On an unknown date, Computerised tomogram: Negative. On an unknown date, Magnetic resonance imaging: Negative.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. The patient eventually had to quit her job. Patient had seen 23 doctors so far. Reporter could not recall dates of vaccination. He could confirm that patient received primary series. Reporter was also unsure if patient received any booster doses.  No treatment medications was reported.
Improperly stored vaccine was administered to a patient. Temperature: 46.5F.; This spontaneous safety report, with reference number 02260497, was received by a partner on 04-OCT-2022 and forwarded on the same day, from a Health Professional.   Due to the nature of the event, the causality between the event "Improperly stored vaccine was administered to a patient. Temperature: 46.5F." and Vaxelis was not applicable.   Further information is expected.  FOLLOW-UP INFORMATION was received by a partner on 06-OCT-2022 and forwarded on 07-OCT-2022. The case is maintained as non-serious.   Due to the nature of the event, the causality between the event "Improperly stored vaccine was administered to a patient. Temperature: 46.5F." and Vaxelis was not applicable.  Further information is expected.
Hypersensitivity cutaneous reaction; Red rash on the inside of her forearm; Itchy rash on the inside of her forearm; Look like mosquito bumps or hives; "Finger tingling"; "Rashes" started popping up in different areas (including the left arm, face, jawline, body) and "alongside her rear"; Chills; Redness; Intense itching; A spontaneous report was received from a nurse concerning a 63-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced hypersensitivity reaction, red rash, itchy rash, hives, tingling, rash all over, chills, redness and itching.  The patient's medical history, as provided by the reporter, includes hypertension, and shingles. Concomitant medications reported includes HCTZ.   On 29 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 010M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 09 Feb 2021 she experienced red and itchy rash on the inside of her forearm, that lasted one-half hour and resolved.  For the past 3 days she reported to have rash on left arm, face, jawline and body. She reported intense itching and redness (that last for 15-20 minutes) associated with the rash looks like hives (that last for about 45 minutes and resolved). She started feeling chills and thingling. She called her HCP. She was diagnosed with known delayed hypersensitivity cutaneous reaction after receiving Moderna's COVID-19 vaccine. Treatment for the events include Benadryl.  Action taken with mRNA-1273 in response to the events was not reported.   The events red rash, itchy rash, hives, redness, itching, rash were resolved.  The events chills, tingling, hypersensitivity reaction were unknown at the time of report.
On March 8, 2021 I started running a mild fever, chills, headache, nausea, diarrhea, severe body aches, stuffy nose, sore throat and extreme fatigue. I took a home COVID test on March 10, 2021 based on my symptoms and the results from the online questionnaire. I am currently awaiting those results as of March 11, 2021. My fever has been gone for 24 hours now, body aches are minimal and I?m just a little fatigued at this point with a minor cough. I had to cancel my appointment for my second dose that was scheduled for Tuesday March 9, 2021. I have not left my home in weeks except for an eye exam on Saturday March 6, 2021 where I could have been exposed to something, even though it was not crowded and all CDC guidelines were being strictly followed.
No additional AE; PROQUAD was administered to a patient after a temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.   On 13-JUL-2022, the patient was vaccinated with an improperly stored dose of  measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W007744, expiration date 04-SEP-2023, once for prophylaxis (dose, vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported).   The vaccine was stored in a temperature of 12.6 degree Fahrenheit (°F) for 1 Hour 6 Minutes. There was no previous temperature excursion reported. No additional adverse event reported. No product quality complaint (PQC) reported.
1045 after receiving vaccines pt c/o itching all over the body. Gave epi pen 0.15 mg IM. Call 911. No wheezing noted, throat's redness or swelling. No rash or hives notes, it alert and o x 3. Pt sent to ER to monitor with Tx and sent home.
pt recv vax & devel elevated liver enzymes;laboratory evaluation revealed bilirubin 13.4 & SGOT 80;f/u MD reported that there was no adverse vax rxn;